Jump To Top

groundrushairsports

You are here:
Home / Posts Tagged "U.S."

U.S.

U.S. to Invest $70 Mln to Boost Access to COVID-19 Tests

(Reuters) – The Biden administration said it will invest $70 million to boost the availability and lower costs of rapid, over-the-counter COVID-19 tests in the United States, as it looks to ease...

U.S. House Urges Tracking of Police Use of Force Against Pets and Their People

Officer-involved pet shootings are estimated to account for the death or injury of thousands of dogs in the U.S. each year. Research reveals these violent encounters disproportionately happen to pets...

Big rise in U.S. teens identifying as gay, bisexual

(HealthDay)—More teens in the United States are reporting their sexual identity as gay, lesbian or bisexual, nationwide surveys show. Between 2015 and 2019, the percentage of 15- to 17-year-olds who...

Vertex Announces U.S. FDA Approval for Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Children With Cystic Fibrosis Ages 6 through 11 With Certain Mutations

BOSTON–(BUSINESS WIRE)–Jun. 9, 2021– Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved expanded use of Trikafta (elexacaftor/tezacaftor/ivacaftor...

U.S. FDA Approves Yescarta for Relapsed or Refractory Follicular Lymphoma After Two or More Lines of Systemic Therapy

SANTA MONICA, Calif.–(BUSINESS WIRE)–Mar. 5, 2021– Kite, a Gilead Company (Nasdaq: GILD), today announced that the U.S. Food and Drug Administration (FDA) has granted...

U.S. could reach herd immunity by late spring

The United States could be approaching herd immunity, which occurs when enough people become immune to a disease to make its spread unlikely, according to Suzanne Judd, Ph.D., an epidemiologist in the...

U.S. Food and Drug Administration Approves Opdivo (nivolumab) in Combination with Cabometyx (cabozantinib) as First-line Treatment for Patients with Advanced Renal Cell Carcinoma

PRINCETON, N.J.–(BUSINESS WIRE) January 22, 2021– Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) 240 mg (injection for intravenous use) every two weeks or 480 mg every...

Survey: Frequent reports of missed medical care in U.S. adults during early phase of COVID-19 pandemic

Two out of five individuals delayed or missed medical care in the early phase of the pandemic—from March through mid-July 2020—according to a new survey from researchers at the Johns Hopkins Bloomberg...

Dental practices rebound as U.S. dentists look forward to COVID vaccine

The coronavirus pandemic hit dental practices hard early in 2020, as COVID-19 fears kept millions of Americans from seeking routine oral health care. But as dental offices have ratcheted up their safety...

Watch a CrossFit Games Competitor Absolutely Crush the U.S. Marine Combat Fitness Test

Military fitness tests like the U.S. Army PFT are a popular source of content for fitness YouTube, with vloggers cranking out pushups, situps and pullups in high volume. But the Marine Corps’ combat...